News - BioCanRx

X About BioCanRx Governance

Equity, Diversity & Inclusion Network Members and Investigators Our Team

X

NEWS & EVENTS > News

2024

Nov 7, 2024
BioCanRx’s 2023-2024 Annual Report is Now Available
Oct 30, 2024
Bridging Canada’s Biotherapeutic Gap: A Call for Strategic Investment in Translational Research
Oct 29, 2024
Pandemic Driven Innovation
Sep 20, 2024
BioCanRx Makes Patients Partners in Immunotherapy Research
Sep 20, 2024
BioCanRx Summer Students Tell All
Jun 24, 2024
And the survey shows…
Jun 5, 2024
Immunotherapy: A Beacon of Hope in Canada’s Fight Against Cancer
May 28, 2024
Federal Investment in Immunotherapy Boosts Hope for Canadian Cancer Patients and Positions Canada as a Global Leader in Cancer Treatment
May 27, 2024
Pandemic Preparedness Brings Benefits For Immunotherapy As Well
May 16, 2024
Where Are They Now – Olivia Craggs
May 13, 2024
2024 Cohort of BioCanRx Summer Students
Mar 27, 2024
New Investment from the Strategic Science Fund & the Future of BioCanRx A Q&A with Dr. Stéphanie Michaud, President and CEO
Mar 27, 2024
Where Are They Now – David Cook
Mar 22, 2024
BioCanRx at the World Indigenous Cancer Conference
Feb 26, 2024
BioCanRx Consultation Survey for Cancer Immunotherapy Research Priorities
Feb 15, 2024
BioCanRx Recognized for Commitment to Inclusion, Diversity, Equity, and Accessibility
Feb 2, 2024
2024 World Cancer Day A Message from BioCanRx
Feb 2, 2024
Empowering Indigenous Youth in STEM: Insights from CSPC 2023 Panel
Feb 1, 2024
ACCESS Call for survey respondents!
Jan 26, 2024
Where Are They Now: Etienne Melese

2023

Dec 11, 2023
Where Are They Now: Landon Steenbakkers
Dec 11, 2023
Both Sides of the Learning Institute Experience at the 2023 Summit for Cancer Immunotherapy
Dec 6, 2023
BioCanRx Welcomes Strategic Science Fund Investment
Nov 7, 2023
2023 Summit4CI: The HQP Experience
Nov 7, 2023
Successful 2023 Summit for Cancer Immunotherapy
Nov 7, 2023
BioCanRx Summer Students Tell All
Nov 1, 2023
What are your Research Priorities for AYA Cancer in Canada?
Oct 18, 2023
IDEA IMPACT STORIES: BIOCANRX
Sep 6, 2023
2023 Imagine Lecture Award Recipient
Sep 6, 2023
Where Are They Now: Taha Azad
Sep 6, 2023
Making CAR T Therapies More Accessible
Jun 6, 2023
Where Are They Now: Jessica Silva
Jun 5, 2023
Examining CAR-T therapy, person by person
Jun 2, 2023
2023 Cohort of BioCanRx Summer Students
May 5, 2023
Summit4CI Registration Now Open!
Mar 29, 2023
From a project to a platform: A new and less expensive way to deliver immunotherapy
Feb 11, 2023
Sharing Insights on International Day of Women and Girls in Science
Feb 2, 2023
World Cancer Day Message from BioCanRx
Jan 30, 2023
Where Are They Now: Nikolas Martin
Jan 27, 2023
Both Sides of the Learning Institute 2022 Experience
Jan 27, 2023
Revolutionizing the treatment of cancer in children
Jan 19, 2023
BioCanRx recognized as I.D.E.A.L. Bioscience Employer

2022

Dec 13, 2022
Summit4CI 2022: Back in-person & better than ever!
Dec 13, 2022
Summit4CI 2022: The HQP Experience
Nov 3, 2022
Taking a Successful Training Approach to the National Level
Nov 1, 2022
CSPC 2022: Interview with Stéphanie Michaud
Nov 1, 2022
CSPC 2022 – Everything Old is New Again: Proven ingredients to successful mission-oriented program design from the NCE program
Nov 1, 2022
CSPC 2022 – Social Pharmaceutical Innovation: Made-in-Canada solutions to address unmet medical needs for advanced therapeutics
Oct 31, 2022
Summer Students Tell All
Oct 20, 2022
Newmarket cancer patient credits made-in-Canada CAR T cell treatment in BioCanRx-funded clinical trial at The Ottawa Hospital for saving her life
Sep 29, 2022
A Personalized Approach to CAR-T Therapy
Sep 29, 2022
Where Are They Now: Gabrielle Siegers
Jul 8, 2022
Summit4CI 2022 – Less than 5 months away!
Jul 8, 2022
Bridging a gap in the path to the clinic
Jun 24, 2022
Where Are They Now: Oliver Varette
Jun 24, 2022
The BioCanRx Team Celebrates Immunotherapy Month!
Jun 24, 2022
National Indigenous People’s Day
May 26, 2022
Cancer Stakeholder Alliance Member Profile: Catherine Wilhelmy Rech
May 24, 2022
Come on down and roll the dice!
May 24, 2022
Introducing the winners of BioCanRx’s 2022 Summer Studentships
Apr 27, 2022
Drilling down to improve CAR T therapy
Apr 27, 2022
Where Are They Now: Julian Smazynski
Mar 22, 2022
Another made-in-Canada CAR-T trial based on Canadian manufacturing capability
Mar 21, 2022
One small step for blood cancer patients, one giant step for Canadian cancer patients of all stripes
Mar 16, 2022
Where Are They Now: Alyssa Vito
Feb 16, 2022
Carl H. June to be Keynote Speaker at 2021 Summit4CI!
Feb 11, 2022
Where Are They Now: James Han
Feb 11, 2022
International Day of Women & Girls in Science 2022: Words of Wisdom
Feb 4, 2022
World Cancer Day Message
Jan 28, 2022
Learning Institute Community Dissemination Report 2021
Jan 21, 2022
Can radiation help immunotherapy work better? And can a healthy gut help as well?
Jan 14, 2022
Where Are They Now: Andrea Vervoort

2021

Dec 16, 2021
Successful Virtual Summit for Cancer Immunotherapy
Dec 10, 2021
Evening the odds for health-system coverage of costly immunotherapies
Dec 10, 2021
The HQP Experience at Summit4CI
Nov 12, 2021
A multi-target improvement for CAR T therapy
Nov 10, 2021
Where Are They Now: Hayley McKay
Nov 9, 2021
CAR T-cell therapy: Canadian patient in landmark trial shares his story
Oct 18, 2021
BioCanRx Summer Students Tell All
Oct 18, 2021
Where Are They Now: Rob Mould
Sep 21, 2021
Where Are They Now: Brittany Umer
Sep 20, 2021
New Partnership Strengthens Biomanufacturing in Canada
Sep 15, 2021
Dr. John Bell Awarded Dr. Chew Wei Memorial Prize in Cancer Research
Sep 14, 2021
Biomanufacturing Partnership Featured in The Ottawa Citizen
Jul 6, 2021
CSA Member Profile Louise Binder, Save Your Skin Foundation & Chair of the BioCanRx – Cancer Stakeholder Alliance Working Group
Jun 29, 2021
General Call for Learning Institute Applications
Jun 29, 2021
2021 Summit for Cancer Immunotherapy Going Virtual
Jun 29, 2021
Nothing about me, without me: Engaging patients in clinical trials
Jun 29, 2021
Indigenous History Month
Jun 29, 2021
Immunotherapy Month: Recognizing the Potential
May 25, 2021
Introducing the winners of BioCanRx’s 2021 Summer Studentships
May 25, 2021
Innovative approaches to strategic training
Apr 26, 2021
Out in the real world
Apr 22, 2021
Where Are They Now: Sarwat Khan
Apr 9, 2021
Treating the untreatable: How and why Canada’s CAR-T cancer network was built
Mar 31, 2021
BioCanRx-funded Researchers Publish Results from CAR T CSEI Project
Mar 24, 2021
When health research saves lives – and creates economic growth to boot!
Mar 23, 2021
Where Are They Now: Piriya Yoganathan
Feb 24, 2021
BioCanRx Welcomes New Board Members
Feb 24, 2021
Bringing immunotherapy to the bedside
Feb 24, 2021
One small step for blood cancer patients, one giant step for Canadian cancer patients of all stripes
Feb 24, 2021
Where Are They Now: Marie-Laurence Tremblay
Feb 9, 2021
Dr. John Bell Interviewed on The Zoomer
Feb 5, 2021
Intellectual capital is Canada’s most important natural resource
Feb 4, 2021
World Cancer Day 2021
Feb 2, 2021
CSA Member Profile: Paul O’Connell
Jan 21, 2021
The BioCanRx progression: A structure for success
Jan 21, 2021
Where Are They Now: Parvez Vora

2020

Dec 15, 2020
Where Are They Now: Laura Evgin
Dec 15, 2020
Protecting people with cancer from COVID-19
Dec 2, 2020
Dr. Jennifer Quizi Featured in Ottawa Citizen: New Canadian BioManufacturing Program
Nov 20, 2020
Carl H. June to be Keynote Speaker at 2021 Summit4CI!
Nov 20, 2020
Where Are They Now: Nicole Forbes
Nov 17, 2020
Making an obvious target attainable
Oct 29, 2020
CSA Member Profile – Niya Chari
Oct 9, 2020
OHRI Interview Study Seeking Researcher Participation: Patient Engagement in Preclinical Research
Oct 7, 2020
BioCanRx Summer Students Tell All
Oct 7, 2020
From “what if” to “what is”
Oct 7, 2020
Where Are They Now? Q&A with Former BioCanRx HQPs
Jul 10, 2020
Ottawa at Work: A clinical trial right here in Ottawa aims to protect cancer patients from COVID-19
Jul 8, 2020
Protecting cancer patients from COVID-19: World-first clinical trial tests a novel immune-boosting strategy
May 28, 2020
Newly-Funded CSEI Projects
May 12, 2020
Introducing the winners of BioCanRx’s 2020 Summer Studentships
May 5, 2020
Announcement from BioCanRx Postponement of the 2020 Summit for Cancer Immunotherapy
May 1, 2020
CBC Interview: COVID-19 Vaccine Research Grant
Apr 29, 2020
Cancer-killing viruses provide inspiration for COVID-19 vaccine
Apr 21, 2020
Improving Vaccine Production to Aid in Pandemic Response
Apr 2, 2020
Ottawa Hospital researchers join the global race to treat, prevent COVID-19
Apr 2, 2020
Researchers join the fight against COVID-19
Mar 25, 2020
I study viruses: How our team isolated the new coronavirus to fight the global pandemic
Mar 11, 2020
U of T researchers hunt for antivirals to treat COVID-19 patients
Feb 4, 2020
World Cancer Day 2020
Jan 9, 2020
Learning Institute Community Dissemination Report 2019

2019

Nov 21, 2019
Dr. John Bell Featured on Science Podcast
Nov 20, 2019
Successful Fourth Summit for Cancer Immunotherapy
Nov 19, 2019
Both Sides of the Learning Institute 2019 Experience
Nov 19, 2019
HQP Knowledge and Network Building at Summit4CI
Sep 11, 2019
BioCanRx Summer Students Tell All
Sep 11, 2019
Rounding to Home Plate: Keeping Immunotherapies From Striking Out
Aug 11, 2019
What the explosion of immunotherapy research means for Canadian cancer patients
Jun 13, 2019
Envisioning Cycle Two at the BioCanRx Cancer Stakeholder Alliance Meeting
May 3, 2019
Summit for Cancer Immunotherapy coming in October! Submit Your Abstract!
May 3, 2019
And … presto!
Apr 25, 2019
Introducing the winners of BioCanRx’s 2019 Summer Studentships
Mar 28, 2019
BioCanRx Cycle II LOI Call
Mar 28, 2019
Diving deep into the abdominal cavity
Mar 27, 2019
BioCanRx Lab Exchange at the Alberta Cell Therapy Manufacturing Facility
Mar 27, 2019
John Bell Wins Inaugural ESGCT Public and Patient Engagement Award
Feb 8, 2019
Giving melanoma the one-two punch
Feb 4, 2019
World Cancer Day 2019: A Message from Dr. John Bell, Scientific Director and Dr. Stéphanie Michaud, President & CEO BioCanRx
Jan 7, 2019
Learning Institute Community Dissemination Report 2018

2018

Dec 20, 2018
An Update on the Director of Scientific Affairs, BioCanRx
Dec 18, 2018
Matchmaker, matchmaker, make me a match…
Dec 18, 2018
Preclinical Experimental Design and Reporting Workshop for Senior Investigators and HQP
Dec 14, 2018
Letter to the BioCanRx Network Community
Nov 21, 2018
Summit4CI 2018: The HQP Experience
Nov 21, 2018
Successful 2018 Summit for Cancer Immunotherapy
Nov 21, 2018
Both Sides of the Learning Institute 2018 Experience
Sep 24, 2018
A deadly conundrum
Sep 24, 2018
Great lineup planned for HQP attending Summit4CI
Sep 21, 2018
BioCanRx Summer Students Tell All
Sep 6, 2018
CDRD Academy Announces Inaugural Cohort in Unique New National Executive Institute
Aug 16, 2018
Talking to the Public About Your Research – Why Bother?
Aug 16, 2018
Making the next big thing possible
Jun 27, 2018
Immunotherapy Month Activities
Jun 27, 2018
2018 Summit for Cancer Immunotherapy in Banff, Alberta
Jun 27, 2018
Where Are They Now? Q&A with Former BioCanRx HQPs
Jun 27, 2018
How to Give an Accessible Presentation: Do’s and Don’ts
Jun 27, 2018
The Economic Side of Immunotherapy Research
Jun 15, 2018
BioCanRx Call for Expressions of Interest
May 29, 2018
BioCanRX and Partners Announce Funding for Eight New Projects
May 29, 2018
Smoothing the road to the clinic
Apr 26, 2018
Introducing the winners of BioCanRx’s 2018 Summer Studentships
Apr 3, 2018
BioCanRx Lab Exchange at the Biotherapeutics Manufacturing Centre in Ottawa
Apr 3, 2018
Improving Anal Cancer Research through the CORMAC Study
Apr 3, 2018
Breaking new ground in immunotherapy to treat cancer
Feb 2, 2018
Coming at cancer immunotherapy through macrophages
Feb 2, 2018
World Cancer Day 2018
Feb 2, 2018
BioCanRx and Partners New Project Funding Announcement
Jan 12, 2018
A Look Back at the First Year of the Cancer Stakeholder Alliance
Jan 12, 2018
From Ottawa to Sao Paulo, Brazil: A BioCanRx Lab Exchange
Jan 3, 2018
Ottawa Scientists Cure Aggressive Breast Cancer in Mice with Combination Therapy

2017

Dec 15, 2017
The Ottawa Regional Cancer Foundation Invests $100,000 in BioCanRx Research Projects
Dec 1, 2017
Put Another Arrow in the Quiver
Dec 1, 2017
Learning Institute Community Dissemination Report 2017
Dec 1, 2017
Lasting Impacts of The Learning Institute
Dec 1, 2017
BioCanRx’s 2016-2017 Annual Report is Now Available
Nov 6, 2017
Dr. John Bell Receives Canadian Cancer Research Alliance Award
Nov 2, 2017
Cancer Clinical Trials Webinar for Cancer Coaches
Nov 1, 2017
PATIENT ENGAGEMENT AT BIOCANRX: BRINGING CANCER PATIENTS AND RESEARCHERS TOGETHER
Oct 30, 2017
Dr. John Bell receives award for Outstanding Achievements in Cancer Research
Oct 21, 2017
Dr. John Bell speaks to CBC News about the FDA approval of a second CAR-T cell therapy
Oct 20, 2017
Developing Cancer Research Communication Skills: Q & A with Candice Tang a Master’s student in Applied Immunology
Oct 20, 2017
From heartbreak to hope
Oct 16, 2017
Cancer-fighting Ottawa startup Turnstone Biologics signs licensing agreement
Sep 26, 2017
Turnstone Biologics named one of FierceBiotech’s 2017 Fierce 15
Sep 8, 2017
New treatment approaches for a stubborn cancer
Sep 8, 2017
The Learning Institute Pilot – Testimonials From Participants
Sep 8, 2017
Meet Two of BioCanRx’s Summer Students
Aug 30, 2017
Dr. John Bell speaks to CBC News on how BioCanRx researchers are working out a made-in-Canada CAR-T cell therapy protocol
Aug 30, 2017
FDA announces historic approval of CAR T-cell therapy to treat certain children and young adults with B-cell acute lymphoblastic leukemia
Aug 16, 2017
New Targeted Funding Call is Now Open
Aug 2, 2017
Next Funding Call for Applications is Now Open
Aug 2, 2017
BioCanRx and Partners Announce Funding for a New Clinical Trial to Treat Hematologic Cancers
Jul 20, 2017
2017 Summit for Cancer Immunotherapy
Jul 20, 2017
Removing obstacles to innovation: BioCanRx core facilities provide essential manufacturing, immune analysis services
Jul 20, 2017
Training is the name of the game at Summit4CI
Jul 20, 2017
Piloting a new Learning Institute at Summit4CI
May 25, 2017
Ottawa cancer researchers to play lead role in new immunotherapy initiative, worth $4 million
May 4, 2017
BioCanRx and partners announce $6.5M in funding for three new projects including a clinical trial
May 4, 2017
Announcing the winners of BioCanRx’s 2017 Summer Studentships
May 4, 2017
Providing Patient Perspective: The Cancer Stakeholder Alliance and Working Group
May 3, 2017
Superhero cells: the next generation of cancer treatment
Apr 27, 2017
BioCanRx Supports Innovative Clinical Trial Combining Experimental Cancer-Killing Viruses and Antibodies
Apr 26, 2017
Ottawa Hospital trial deploys viruses and an immunotherapy drug to combat lung cancer
Apr 26, 2017
Cancer patients begin experimental viral treatment
Apr 3, 2017
Cancer Immunotherapy Journalism and Mentoring Fellowship
Mar 30, 2017
Combining strengths to fight Cancer: BioCanRx supports the translation of key immunotherapy discoveries to the clinic
Mar 29, 2017
Treating bladder cancer with an engineered virus
Mar 22, 2017
Moving from the lab to the clinic
Feb 15, 2017
Ottawa poised to become manufacturing centre for cancer-fighting agent
Feb 15, 2017
BioCanRx, and partners, announce funding to manufacture first made-in-Canada CAR-T cells
Feb 2, 2017
Sometimes the whole is greater than the sum of its parts
Feb 1, 2017
World Cancer Day 2017
Feb 1, 2017
Teaching cancer biotherapeutics in the North

2016

Dec 9, 2016
Cells… in a box
Nov 2, 2016
2016 BioCanRx Summer Studentships
Nov 2, 2016
Helping scientists do science better, one failure at a time
Sep 16, 2016
BioCanRx researchers featured in the Ottawa Citizen
Sep 14, 2016
Manufacturing cancer-fighting viruses in Canada
Sep 14, 2016
Adding muscle to the immune system to fight ovarian cancer
Aug 2, 2016
From pioneer to pioneers: a patient view on research
Aug 2, 2016
Finding the sweet spot: A tricky job for the right virus to treat brain cancer
Jun 26, 2016
Dr. Ira Mellman discusses cancer immunotherapy
Mar 18, 2016
Global News takes a look into the science of immunotherapy
Feb 16, 2016
World-first clinical trial for oncolytic virus immunotherapy featured by The National

2015

Oct 27, 2015
First cancer-killing virus therapy approved by the FDA
Oct 19, 2015
“Heal, boy: How companion animals can help find cures for human cancer” (The Globe and Mail)
Sep 30, 2015
BioCanRx investigators receive $5M to develop virus therapy for prostate cancer
Sep 17, 2015
Dr. John Bell named Top 25 in Ottawa
Sep 16, 2015
Dr. Rebecca Auer receives grant from Canadian Cancer Society

Media Contact

Vanessa Nelson
Director, Communications
613-739-6203
vnelson@biocanrx.com